108 related articles for article (PubMed ID: 15221977)
21. [Tissue factor expression in human umbilical vien endothelial cells stimulated by TNF-alpha and its molecular mechanism].
Song SJ; Wang LL; Wei WN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Apr; 11(2):124-7. PubMed ID: 12744731
[TBL] [Abstract][Full Text] [Related]
22. Expression of tissue factor pathway inhibitor by cultured endothelial cells in response to inflammatory mediators.
Ameri A; Kuppuswamy MN; Basu S; Bajaj SP
Blood; 1992 Jun; 79(12):3219-26. PubMed ID: 1596565
[TBL] [Abstract][Full Text] [Related]
23. Retinoic acid counteracts both the downregulation of thrombomodulin and the induction of tissue factor in cultured human endothelial cells exposed to tumor necrosis factor.
Ishii H; Horie S; Kizaki K; Kazama M
Blood; 1992 Nov; 80(10):2556-62. PubMed ID: 1330076
[TBL] [Abstract][Full Text] [Related]
24. Induction of tissue factor expression on human umbilical vein endothelial cells by cell-specific HLA class I antibody: preliminary data.
Naji A; Deschaseaux F; Racadot E; Ferrand C; Justrabo E; Guignier F; Mousson C; Rifle G
Transplant Proc; 2005; 37(6):2892-3. PubMed ID: 16182846
[TBL] [Abstract][Full Text] [Related]
25. Refractory period phenomenon in the induction of tissue factor expression on endothelial cells.
Busso N; Huet S; Nicodème E; Hiernaux J; Hyafil F
Blood; 1991 Oct; 78(8):2027-35. PubMed ID: 1717079
[TBL] [Abstract][Full Text] [Related]
26. Antiparasitic treatment of patients with P. falciparum malaria reduces the ability of patient serum to induce tissue factor by decreasing NF-kappa B activation.
Bierhaus A; Hemmer CJ; Mackman N; Kutob R; Ziegler R; Dietrich M; Nawroth PP
Thromb Haemost; 1995 Jan; 73(1):39-48. PubMed ID: 7740494
[TBL] [Abstract][Full Text] [Related]
27. Cdc2-like kinases and DNA topoisomerase I regulate alternative splicing of tissue factor in human endothelial cells.
Eisenreich A; Bogdanov VY; Zakrzewicz A; Pries A; Antoniak S; Poller W; Schultheiss HP; Rauch U
Circ Res; 2009 Mar; 104(5):589-99. PubMed ID: 19168442
[TBL] [Abstract][Full Text] [Related]
28. Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40.
Slupsky JR; Kalbas M; Willuweit A; Henn V; Kroczek RA; Müller-Berghaus G
Thromb Haemost; 1998 Dec; 80(6):1008-14. PubMed ID: 9869175
[TBL] [Abstract][Full Text] [Related]
29. Role of tumor necrosis factor alpha in hyperthermia-induced apoptosis of human leukemia cells.
Katschinski DM; Robins HI; Schad M; Frede S; Fandrey J
Cancer Res; 1999 Jul; 59(14):3404-10. PubMed ID: 10416602
[TBL] [Abstract][Full Text] [Related]
30. Intermitted pharmacologic pretreatment by xenon, isoflurane, nitrous oxide, and the opioid morphine prevents tumor necrosis factor alpha-induced adhesion molecule expression in human umbilical vein endothelial cells.
Weber NC; Kandler J; Schlack W; Grueber Y; Frädorf J; Preckel B
Anesthesiology; 2008 Feb; 108(2):199-207. PubMed ID: 18212564
[TBL] [Abstract][Full Text] [Related]
31. [Expression of tissue factor induced by IL-6 in HUVEC].
Tang XL; Jiang ZY; Dong J; Liu XC; Cai SY; Xiao R; Lu YR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):234-7. PubMed ID: 16608083
[TBL] [Abstract][Full Text] [Related]
32. Increased human tumor necrosis factor-α levels induce procoagulant change in porcine endothelial cells in vitro.
Lee KG; Lee H; Ha JM; Lee YK; Kang HJ; Park CG; Kim SJ
Xenotransplantation; 2012; 19(3):186-95. PubMed ID: 22702470
[TBL] [Abstract][Full Text] [Related]
33. Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors.
Kirchhofer D; Tschopp TB; Hadváry P; Baumgartner HR
J Clin Invest; 1994 May; 93(5):2073-83. PubMed ID: 8182139
[TBL] [Abstract][Full Text] [Related]
34. [Effects of tetramethylpyrazine on thrombin-induced tissue factor expression in vascular endothelial cells].
Cheng CY; Sun Y; Wen ZB; He XF; Wang GF; Lin GQ; Jiang HH; Tian XM; He SL
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Aug; 29(8):1743-7. PubMed ID: 19726327
[TBL] [Abstract][Full Text] [Related]
35. Comparison of tissue factor pathway in human umbilical vein and adult saphenous vein endothelial cells: implications for newborn hemostasis and for laboratory models of endothelial cell function.
Grabowski EF; Carter CA; Ingelfinger JR; Tsukurov O; Conroy N; Abbott WM; Orkin RW
Pediatr Res; 1999 Dec; 46(6):742-7. PubMed ID: 10590033
[TBL] [Abstract][Full Text] [Related]
36. C5a induces tissue factor activity on endothelial cells.
Ikeda K; Nagasawa K; Horiuchi T; Tsuru T; Nishizaka H; Niho Y
Thromb Haemost; 1997 Feb; 77(2):394-8. PubMed ID: 9157602
[TBL] [Abstract][Full Text] [Related]
37. Shiga toxin enhances functional tissue factor on human glomerular endothelial cells: implications for the pathophysiology of hemolytic uremic syndrome.
Nestoridi E; Tsukurov O; Kushak RI; Ingelfinger JR; Grabowski EF
J Thromb Haemost; 2005 Apr; 3(4):752-62. PubMed ID: 15842359
[TBL] [Abstract][Full Text] [Related]
38. Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB-dependent pathways in cultured human umbilical vein endothelial cells.
Hamaguchi E; Takamura T; Shimizu A; Nagai Y
J Pharmacol Exp Ther; 2003 Dec; 307(3):987-94. PubMed ID: 14534369
[TBL] [Abstract][Full Text] [Related]
39. Shiga toxin downregulates tissue factor pathway inhibitor, modulating an increase in the expression of functional tissue factor on endothelium.
Grabowski EF; Kushak RI; Liu B; Ingelfinger JR
Thromb Res; 2013 Jun; 131(6):521-8. PubMed ID: 23642803
[TBL] [Abstract][Full Text] [Related]
40. Glabridin suppresses intercellular adhesion molecule-1 expression in tumor necrosis factor-alpha-stimulated human umbilical vein endothelial cells by blocking sphingosine kinase pathway: implications of Akt, extracellular signal-regulated kinase, and nuclear factor-kappaB/Rel signaling pathways.
Kang JS; Yoon YD; Han MH; Han SB; Lee K; Lee KH; Park SK; Kim HM
Mol Pharmacol; 2006 Mar; 69(3):941-9. PubMed ID: 16354764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
